Outcome of High-Risk Stage 3 Neuroblastoma with Myeloablative Therapy and 13-cis-Retinoic Acid: A Report from the Children’s Oncology Group

BACKGROUND: The components of therapy required for patients with INSS Stage 3 neuroblastoma and high risk features remain controversial. PROCEDURE: A retrospective cohort design was used to determine if intensive chemoradiotherapy with purged autologous bone marrow rescue (ABMT) and/or 13-cis-retino...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: Park, Julie R., Villablanca, Judith G., London, Wendy B., Gerbing, Robert B., Haas-Kogan, Daphne, Stanton Adkins, E., Attiyeh, Edward F., Maris, John M., Seeger, Robert C., Patrick Reynolds, C., Matthay, Katherine K.
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: 2009
Gaiak:
Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC2731719/
https://ncbi.nlm.nih.gov/pubmed/18937318
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/pbc.21784
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak